Oat - ornithine aminotransferase Gene

Also Known as rhg

Species: Mus musculus

Gene Type: protein coding
Gene ID: 18242

Summary

Predicted to enable identical protein binding activity; pyridoxal phosphate binding activity; and transaminase activity. Predicted to be involved in arginine catabolic process to glutamate and arginine catabolic process to proline via ornithine. Located in mitochondrion. Is expressed in several structures, including alimentary system; brain; integumental system; respiratory system; and sensory organ. Used to study gyrate atrophy. Human ortholog(s) of this gene implicated in gyrate atrophy. Orthologous to human OAT (ornithine aminotransferase). [provided by Alliance of Genome Resources, Apr 2022]

Oat Products (1)

mRNA Protein Name
NM_016978.2 NP_058674.1 ornithine aminotransferase, mitochondrial precursor
Protein Preferred Names Protein Names

ornithine aminotransferase, mitochondrial

  • ornithine--oxo-acid aminotransferase

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (11)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-50896 Erlotinib Inhibitor 99.99% Yes
HY-15592 Cabotegravir Inhibitor 99.92% Unkown
HY-12008 Erlotinib Hydrochloride Inhibitor 99.94% Yes
HY-50896R Erlotinib (Standard) Inhibitor 99.97% Unkown
HY-15258 Lesinurad Inhibitor 99.96% Unkown
HY-B0396 Tebipenem pivoxil Substrate 99.68% Unkown
HY-15592A Cabotegravir sodium Inhibitor 99.87% Unkown
HY-12008R Erlotinib Hydrochloride (Standard) Inhibitor 99.73% Unkown
HY-15258A Lesinurad sodium Inhibitor 99.79% Unkown
HY-B0396A Tebipenem pivoxil hydrochloride Substrate / Unkown
HY-12008A Erlotinib mesylate Inhibitor / Unkown

Clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-111345 Epaminurad Inhibitor 99.75% Phase 3
HY-16278A Pradigastat sodium Inhibitor / Phase 3

Pre-clinical Phase

Bioactive Molecules (35)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-154021A 5-Fluoromethylornithine dihydrochloride Inhibitor 99.08% Unkown
HY-N3513 Mulberrin Inhibitor 99.94% Unkown
HY-16278 Pradigastat Inhibitor 99.88% Unkown
HY-122009 Indican Inhibitor 99.88% Unkown
HY-B0927 Hydrastine Inhibitor 99.57% Unkown
HY-W585842 Estradiol 3-glucuronide Substrate 98.00% Unkown
HY-133825 Cyazofamid Inhibitor 98.15% Unkown
HY-W002438 6-Hydroxyindole Inhibitor 99.98% Unkown
HY-126848 Diclofenac acyl glucuronide Substrate 98.34% Unkown
HY-N3504 Ophiopogonin D' Modulator 99.94% Unkown
HY-148682 18β-Glycyrrhetyl-3-O-sulfate Inhibitor 98.71% Unkown
HY-50896S Erlotinib-d6 Inhibitor 99.84% Unkown
HY-N7755 Estradiol 3-glucuronide sodium Substrate 98% Unkown
HY-12008S Erlotinib-d6 hydrochloride Inhibitor 98.13% Unkown
HY-B0396B Tebipenem pivoxil hydrobromide Substrate / Unkown
HY-137846A PF-05221304 tromethamine Substrate / Unkown
HY-184557 DZ-1-DHA / Unkown
HY-16443 S-4048 / Unkown
HY-155485 Abi-DZ-1 / Unkown
HY-N12007 OAT1/3-IN-1 / Unkown
HY-138142 Euphol acetate Inhibitor / Unkown
HY-D3239 AF405 NHS Ester Substrate / Unkown
HY-175645 NLRP3/URAT1-IN-1 Inhibitor / Unkown
HY-N12008 OAT1/3-IN-2 / Unkown
HY-182542 SOAT-IN-3 Inhibitor / Unkown
HY-50896S1 Erlotinib-13C6 Inhibitor / Unkown
HY-W740244 4’-Hydroxy Trazodone / Unkown
HY-12008S1 Erlotinib-13C6 hydrochloride Inhibitor / Unkown
HY-15592S4 Cabotegravir-d6 Inhibitor / Unkown
HY-50896S3 Erlotinib-d8 Inhibitor / Unkown
HY-180227 URAT1-IN-15 Inhibitor / Unkown
HY-111345A Epaminurad hydrochloride Inhibitor / Unkown
HY-15258S1 Lesinurad-d4 Inhibitor / Unkown
HY-124706 DRAinh-A250 Inhibitor / Unkown
HY-50896S2 Erlotinib-d4 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Oat NCBI NCBI:4942